期刊文献+

顽固性高血压临床诊疗分析 被引量:1

Analysis of clinical diagnosis and treatment for resistant hypertension
下载PDF
导出
摘要 目的总结本院收治的顽固性高血压患者的临床病因以及调治手段。方法采用回顾性分析法统计分析92例顽固性高血压患者的临床资料,分析其临床病因以及治疗后转归特点。结果 92例患者中,以Ⅲ期最多,占65.22%,基础疾病以高血压性心脏病和高血压性肾脏功能损害为主,分别占31.52%和15.22%;患者中有12例为假性顽固性高血压,此外有39.13%的患者为药物搭配使用不合理;经积极治疗后84例患者血压均完全达标,其余8例患者有2例转院,6例患者在本院其他科室中给予手术或透析治疗后均恢复正常。结论顽固性高血压发病原因和诱因较多,在治疗时给予多重筛查,个体化治疗,可稳定其血压。 Objective To summarize clinical pathogeny and treatment measures for resistant hypertension patients in our hospital. Methods Clinical data of 92 patients with resistant hypertension were retrospectively analyzed, along with further analysis of clinical pathogeny and prognosis characteristics after treatment. Results Stage Ⅲ cases accounted for the highest proportion in 92 cases as 65.22%. Main underlying diseases included hypertensive heart disease and hypertensive renal function damage, accounting for 31.52% and 15.22% respectively. There were 12 cases with pseudo resistant hypertension, along with 39.13% of them having unreasonable drug application. After positive treatment, there were 84 patients with standard blood pressure. Among the other 8 cases, there were 2 transferred cases and 6 healed cases after receiving surgery or dialysis therapy in other departments. Conclusion Due to various pathogeny and inducements in resistant hypertension, implement of multiple screening and individualized treatment can stabilize blood pressure in patients.
作者 李坚
出处 《中国实用医药》 2016年第27期33-34,共2页 China Practical Medicine
关键词 顽固性高血压 临床特点 治疗效果 病因 Resistant hypertension Clinical characteristics Curative effect Pathogeny
  • 相关文献

参考文献11

二级参考文献80

  • 1黄平,吴健.老年顽固性高血压[J].保健医苑,2005(6):40-42. 被引量:5
  • 2梁峰,胡大一,吴明营.顽固性高血压治疗的现状与进展[J].中华高血压杂志,2010,18(7):631-634. 被引量:21
  • 3胡大一,马长生.心脏病学实践2008[M].北京:人民卫生出版社,2008.374-379.
  • 4胡大一.心血管内科学[M].北京:人民卫生出版社,2009:248-250.
  • 5Calhoun DA,Jones D, Textor S,et al. Rsistant hypertension : diagnosis , evaluation and treatment. A scientific statement from the American Heart Association Prefessional Education Committee of the council for High Blood pressurs Research[J]. Hypertension ,2008, 51(6) :1 403 -1 419.
  • 6胡大一,马长生.心脏病学实践[M].北京:人民卫生出版社,2008:14-17.
  • 7Enseleit F,Luscher TF,Ruschitzka F.Darusentan:a new perspective for treatment of resistant hypertension[J].Expert Opin Investig Drugs,2008,17(8):1255.
  • 8蔡薇,陆永怡,陈群,刘静,王健康.缬沙坦、卡维地洛、复方盐酸阿米洛利联合治疗难治性高血压临床观察[J].中华高血压杂志,2007,15(9):771-772. 被引量:15
  • 9中国高血压防治指南修订委员会.中国高血压防治指南[M].北京:人民卫生出版社,2010:31.
  • 10Tomei G, Sancini A, Tomei F, et al. Prevalence of systemic arterial hypertension, electrocardiogram ab- normalities, and noise-induced hearing loss in agricul- tural workers. Arch Environ Occup Health, 2013, 68(4) :196-203.

共引文献62

同被引文献9

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部